Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$8.94 USD
-0.02 (-0.22%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $8.93 -0.01 (-0.11%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth B Momentum A VGM
Precision BioSciences (DTIL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$34.50 | $60.00 | $19.00 | 285.04% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Precision BioSciences comes to $34.50. The forecasts range from a low of $19.00 to a high of $60.00. The average price target represents an increase of 285.04% from the last closing price of $8.96.
Analyst Price Targets (4 )
Broker Rating
Precision BioSciences currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on five recommendations.
Of the four recommendations deriving the current ABR, three are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.40 | 1.40 | 1.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/22/2024 | H.C. Wainwright & Co. | Patrick Trucchio | Strong Buy | Strong Buy |
4/30/2024 | Guggenheim Securities | Debjit Chattopadhyay | Not Available | Strong Buy |
4/1/2024 | BMO Capital Markets | Kostas Biliouris | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 4 |
Average Target Price | $34.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 87 of 252 |
Current Quarter EPS Est: | -0.79 |
DTIL FAQs
Precision BioSciences, Inc. (DTIL) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Precision BioSciences, Inc. (DTIL) is $34.50. The current on short-term price targets is based on 1 reports.
The forecasts for Precision BioSciences, Inc. (DTIL) range from a low of $19 to a high of $60. The average price target represents a increase of $285.91 from the last closing price of $8.94.
The current UPSIDE for Precision BioSciences, Inc. (DTIL) is 285.91%
Based on short-term price targets offered by four analysts, the average price target for Precision BioSciences comes to $34.50. The forecasts range from a low of $19.00 to a high of $60.00. The average price target represents an increase of 285.04% from the last closing price of $8.96.